HOSPITAL UNIVERSITARIO RUBER
Département
Centro Medico Teknon
Barcelona, EspañaPublications en collaboration avec des chercheurs de Centro Medico Teknon (16)
2024
-
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer
International Journal of Molecular Sciences, Vol. 25, Núm. 7
2023
-
Experience With a Non-Hormonal Centella Asiatica, Hyaluronic Acid and Prebiotic-Based Vaginal Gel in Women With Recurrent Vulvovaginal Candidiasis: Case Studies
Clinical Medicine Insights: Case Reports, Vol. 16
2020
-
Enhancing global access to cancer medicines
CA Cancer Journal for Clinicians, Vol. 70, Núm. 2, pp. 105-124
-
Molecular features of metaplastic breast carcinoma: An infrequent subtype of triple negative breast carcinoma
Cancers, Vol. 12, Núm. 7, pp. 1-13
2019
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
The Lancet Oncology, Vol. 19, Núm. 6, pp. 812-824
-
Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy
Melanoma Research, Vol. 28, Núm. 3, pp. 195-203
-
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
Annals of Oncology, Vol. 29, Núm. 4, pp. 881-887
-
Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis
Clinical Breast Cancer, Vol. 18, Núm. 5, pp. e919-e926
2017
-
The effects of allogenic stem cells in a murine model of hind limb diabetic ischemic tissue
PeerJ, Vol. 2017, Núm. 8
-
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies
Cancer Treatment Reviews, Vol. 61, pp. 53-60
2015
-
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
Breast Cancer: Targets and Therapy, Vol. 7, pp. 125-132
2014
2013
-
Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance
Journal of the American College of Cardiology, Vol. 62, Núm. 17, pp. 1621-1631
2007
-
Investigación neonatal en España
Anales de Pediatria